Literature DB >> 30551736

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.

Daniel Schöttle1, Wolfgang Janetzky2, Daniel Luedecke3, Elmar Beck4, Christoph U Correll5,6,7, Klaus Wiedemann3.   

Abstract

Following publication of the original article.

Entities:  

Year:  2018        PMID： 30551736      PMCID： PMC6295094          DOI： 10.1186/s12888-018-1968-4

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN： 1471-244X            Impact factor:   3.630


Correction to: BMC Psychiatry (2018) 18:365 https://doi.org/10.1186/s12888-018-1946-x Following publication of the original article [1], the authors notified us that the color labelling in Fig. 4 was incorrect. The corrected Fig. 4 is presented below.
Fig. 4

Effects of AOM treatment on Brief Psychiatric Rating Scale (BPRS), global score (values of all items added up) in patients ≤35 years or > 35 years. 18: symptoms not present, 126: symptoms extremely severe. Error bars represent standard deviations

Effects of AOM treatment on Brief Psychiatric Rating Scale (BPRS), global score (values of all items added up) in patients ≤35 years or > 35 years. 18: symptoms not present, 126: symptoms extremely severe. Error bars represent standard deviations
  1 in total

1.  Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.

Authors:  Daniel Schöttle; Wolfgang Janetzky; Daniel Luedecke; Elmar Beck; Christoph U Correll; Klaus Wiedemann
Journal:  BMC Psychiatry       Date:  2018-11-14       Impact factor: 3.630
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.